Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction

Affiliations

¹ Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.
² SIRIO MEDICINE Cardiovascular research network, VA, USA.
³ Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
⁴ Department of Emergency and Organ Transplant, Cardiology Unit, Bari University Hospital, Bari, Italy.
⁵ Division of Cardiology and Structural Heart DiseasesMedical University of Silesia, Katowice, Poland.
⁶ Department of Cardiovascular Medicine, Humanitas Research Hospital, Rozzano, Italy.
⁷ Department of Cardiology, Livorno Hospital, Azienda Usl Toscana Nord-Ovest, Ospedali Riuniti di Livorno, Livorno, Italy.
⁸ Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

Editorial

Eliano P Navarese et al. J Thorac Dis. 2018 Jan.

. 2018 Jan;10(1):17-20.

doi: 10.21037/jtd.2017.11.125.

¹ Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.
² SIRIO MEDICINE Cardiovascular research network, VA, USA.
³ Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria.
⁴ Department of Emergency and Organ Transplant, Cardiology Unit, Bari University Hospital, Bari, Italy.
⁵ Division of Cardiology and Structural Heart DiseasesMedical University of Silesia, Katowice, Poland.
⁶ Department of Cardiovascular Medicine, Humanitas Research Hospital, Rozzano, Italy.
⁷ Department of Cardiology, Livorno Hospital, Azienda Usl Toscana Nord-Ovest, Ospedali Riuniti di Livorno, Livorno, Italy.
⁸ Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials.
Jobs A, Mehta SR, Montalescot G, Vicaut E, Van't Hof AWJ, Badings EA, Neumann FJ, Kastrati A, Sciahbasi A, Reuter PG, Lapostolle F, Milosevic A, Stankovic G, Milasinovic D, Vonthein R, Desch S, Thiele H. Jobs A, et al. Lancet. 2017 Aug 19;390(10096):737-746. doi: 10.1016/S0140-6736(17)31490-3. Epub 2017 Aug 1. Lancet. 2017. PMID: 28778541 Review.

1. Chung SC, Gedeborg R, Nicholas O, et al. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet 2014;383:1305-12. 10.1016/S0140-6736(13)62070-X - DOI - PMC - PubMed
1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014;129:e28-e292. 10.1161/01.cir.0000441139.02102.80 - DOI - PMC - PubMed
1. Freisinger E, Fuerstenberg T, Malyar NM, et al. German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life. Eur Heart J 2014;35:979-88. 10.1093/eurheartj/ehu043 - DOI - PubMed
1. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315. 10.1093/eurheartj/ehv320 - DOI - PubMed
1. Fox KA, Clayton TC, Damman P, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol 2010;55:2435-45. 10.1016/j.jacc.2010.03.007 - DOI - PubMed